Bionano Genomics, Inc. (BMV:BNGO)
Mexico · Delayed Price · Currency is MXN 39.00
+2.00 (5.41%)
At close: Oct 9, 2025
Bionano Genomics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Net Income | -74.33 | -112.02 | -232.49 | -132.6 | -72.44 | -41.11 | Upgrade |
Depreciation & Amortization | 13.05 | 14.23 | 13.91 | 9.84 | 3.37 | 1.48 | Upgrade |
Stock-Based Compensation | 6.81 | 9.74 | 15.18 | 22.42 | 9.72 | 1.55 | Upgrade |
Other Adjustments | -6.83 | 14.73 | 92.99 | 3.46 | -4.93 | 3.2 | Upgrade |
Change in Receivables | 2.33 | 4.14 | -2.3 | -2.25 | -0.49 | 2.09 | Upgrade |
Changes in Inventories | 2.32 | -0.59 | -4.15 | -23.68 | -15.93 | -4.2 | Upgrade |
Changes in Accounts Payable | -2.49 | -3.42 | -2 | 1.95 | 6.78 | -1.81 | Upgrade |
Changes in Accrued Expenses | -1.74 | -1.99 | -2.52 | 0.37 | 3.96 | 1.48 | Upgrade |
Changes in Other Operating Activities | 4.3 | 6.26 | -3.81 | -4.33 | -1.97 | -1 | Upgrade |
Operating Cash Flow | -26.06 | -68.92 | -125.18 | -124.82 | -71.93 | -38.31 | Upgrade |
Capital Expenditures | - | -0.1 | -1.69 | -3.2 | -1.46 | - | Upgrade |
Sale of Property, Plant & Equipment | - | - | - | 0.03 | - | - | Upgrade |
Purchases of Intangible Assets | - | - | - | -0.1 | - | - | Upgrade |
Purchases of Investments | -198.08 | -233.02 | -111.26 | -84.2 | -313.39 | - | Upgrade |
Proceeds from Sale of Investments | 183.61 | 306.96 | 137.02 | 200.89 | 86.48 | - | Upgrade |
Payments for Business Acquisitions | - | - | - | -31.34 | -49.09 | -2.45 | Upgrade |
Proceeds from Business Divestments | - | - | 0.1 | 0.69 | - | - | Upgrade |
Other Investing Activities | - | - | - | - | -0.61 | - | Upgrade |
Investing Cash Flow | -14.47 | 73.84 | 24.16 | 82.77 | -278.06 | -2.45 | Upgrade |
Short-Term Debt Issued | - | - | - | - | - | 0.76 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | - | -2.26 | Upgrade |
Net Short-Term Debt Issued (Repaid) | - | - | - | - | - | -1.5 | Upgrade |
Long-Term Debt Issued | - | 16.25 | 75.48 | - | - | 1.77 | Upgrade |
Long-Term Debt Repaid | -6.62 | -71.43 | -9.05 | -0.04 | -15.01 | -5 | Upgrade |
Net Long-Term Debt Issued (Repaid) | -6.62 | -55.18 | 66.43 | -0.04 | -15.01 | -3.23 | Upgrade |
Issuance of Common Stock | 30.63 | 41.5 | 56.38 | 23.04 | 351.12 | 66.63 | Upgrade |
Net Common Stock Issued (Repurchased) | 30.63 | 41.5 | 56.38 | 23.04 | 351.12 | 66.63 | Upgrade |
Other Financing Activities | - | - | -9 | - | - | - | Upgrade |
Financing Cash Flow | 22.27 | -13.69 | 113.82 | 23.01 | 336.11 | 61.9 | Upgrade |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -0.01 | -0.01 | 0.07 | -0.04 | - | - | Upgrade |
Net Cash Flow | -18.27 | -8.78 | 12.86 | -19.08 | -13.88 | 21.14 | Upgrade |
Beginning Cash & Cash Equivalents | 21.83 | 18.35 | 5.49 | 24.57 | 38.45 | 17.31 | Upgrade |
Ending Cash & Cash Equivalents | 3.56 | 9.57 | 18.35 | 5.49 | 24.57 | 38.45 | Upgrade |
Free Cash Flow | -26.06 | -69.03 | -126.87 | -128.02 | -73.39 | -38.31 | Upgrade |
FCF Margin | -95.03% | -224.28% | -351.29% | -460.46% | -408.14% | -450.59% | Upgrade |
Free Cash Flow Per Share | -11.32 | -54.31 | -222.97 | -265.58 | -159.09 | -220.51 | Upgrade |
Levered Free Cash Flow | -65.52 | -152.81 | -166.31 | -151.68 | -92.69 | -49.88 | Upgrade |
Unlevered Free Cash Flow | -56.63 | -89.57 | -215.44 | -148.85 | -87.99 | -42.57 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.